Jingcao Huang

5PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - lipidsMolecular targetsHaematological tumoursMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 08, 2025
Chidamide and cytarabine synergistically treat acute myeloid leukemia: inhibiting ribosome biogenesis via the MYC-RRP9 pathway.

Qing Li, Fangfang Wang, Xinrong Xiang

|Aug 13, 2024
Dihydrolipoamide dehydrogenase (DLD) is a novel molecular target of bortezomib.

Yu Feng, Hongmei Luo, Jingcao Huang

|Feb 11, 2022
ALCAM regulates multiple myeloma chemoresistant side population.

Fangfang Wang, Zhang Dan, Hongmei Luo

|Sep 30, 2021
ALCAM-EGFR interaction regulates myelomagenesis.

Hongmei Luo, Dan Zhang, Fangfang Wang

|May 16, 2021
BMI1 regulates multiple myeloma-associated macrophage's pro-myeloma functions.

Danfeng Zhang, Jingcao Huang, Fangfang Wang

Pageof 1

Frequent Collaborators

3 joint publications

Qing Yi

3 joint publications

Yuhuan Zheng

1 joint publications

Qiang Wang

1 joint publications

Yiguo Hu